BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12085187)

  • 1. Somatic glypican 3 (GPC3) mutations in Wilms' tumour.
    White GR; Kelsey AM; Varley JM; Birch JM
    Br J Cancer; 2002 Jun; 86(12):1920-2. PubMed ID: 12085187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glypican 3 (GPC3) in embryonal tumors.
    Saikali Z; Sinnett D
    Int J Cancer; 2000 Sep; 89(5):418-22. PubMed ID: 11008203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation analysis of the glypican 3 gene in embryonal tumours.
    Boily G; Saikali Z; Sinnett D
    Br J Cancer; 2004 Apr; 90(8):1606-11. PubMed ID: 15083193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-3 expression in Wilms tumor and hepatoblastoma.
    Toretsky JA; Zitomersky NL; Eskenazi AE; Voigt RW; Strauch ED; Sun CC; Huber R; Meltzer SJ; Schlessinger D
    J Pediatr Hematol Oncol; 2001 Nov; 23(8):496-9. PubMed ID: 11878776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the p53 gene by PCR-SSCP in ten cases of Wilms' tumor.
    Defavery R; Lemos JA; Kashima S; Bernardes JE; Scridelli CA; Covas DT; Tone LG
    Sao Paulo Med J; 2000 Mar; 118(2):49-52. PubMed ID: 10772697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
    Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G
    Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of p53 in Wilms' tumors.
    Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
    Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
    Grubb GR; Yun K; Reeve AE; Eccles MR
    Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Simpson-Golabi-Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis.
    Gillan TL; Hughes R; Godbout R; Grundy PE
    Am J Med Genet A; 2003 Sep; 122A(1):30-6. PubMed ID: 12949968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
    Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
    Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican 3 overexpression in primary and metastatic Wilms tumors.
    Tretiakova M; Zynger DL; Luan C; Andeen NK; Finn LS; Kocherginsky M; Teh BT; Yang XJ
    Virchows Arch; 2015 Jan; 466(1):67-76. PubMed ID: 25366870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
    Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
    Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the WT1 gene in Wilms' tumour.
    Haber DA; Housman DE
    Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
    Xuan JY; Hughes-Benzie RM; MacKenzie AE
    J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new WT1 mutation in a sporadic Wilms' tumour.
    Santos AC; Boavida MG; Costa A; Osorio-Almeida L
    Biochim Biophys Acta; 1998 Aug; 1407(2):109-13. PubMed ID: 9685601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
    Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
    Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.